Results 301 to 310 of about 6,560,912 (366)

Opportunities and barriers for innovation at the interface of engineering and maternal-fetal medicine. [PDF]

Commun Eng
Howlett TS, Parchem JG, Swingle KL.
europepmc   +1 more source

Pre‐analytical optimization of cell‐free DNA and extracellular vesicle‐derived DNA for mutation detection in liquid biopsies

Molecular Oncology, EarlyView.
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen, Lucrezia De Santis, Bret M. Stephens, Vincent Bernard, Jörg C. Kalff, Lara Braun, Phillipp Leyendecker, Johannes Röttgen, Daniel Weissinger, Anirban Maitra, Paola A. Guerrero, Alexander Semaan   +11 more
wiley   +1 more source

Development and validation of a HPLC method for therapeutic monitoring of brivaracetam. [PDF]

Biochem Med (Zagreb)
Komljenović S, Zovko S, Bujan Kovač A, Petelin Gadže Ž, Sertić M, Lovrić M.   +5 more
europepmc   +1 more source

Locoregional Delivery of miRNAs for Glioblastoma Treatment: A Systematic Review of Advances in Delivery Systems. [PDF]

Pharmaceutics
Priya Dharshini LC, Gaiamova E, Serreau R, Garcion E, Morisset-Lopez S, Baril P.   +5 more
europepmc   +1 more source

Cell-Derived Nanocarriers for Monocyte-Mediated Therapeutic Delivery: Concept and Challenges. [PDF]

Yonsei Med J
Yu SE, Kim J, Sung HJ.
europepmc   +1 more source

Therapeutic embolic agents for targeted drug delivery in transcatheter therapies: a review.

Chem Commun (Camb)
Zhao K, Chen P, Varghese P J G, Hosseini-Siyanaki MR, Talaie R, Arzani A, Kim C, Hu J.   +7 more
europepmc   +1 more source